NYSE:HIMS
Hims & Hers Health, Inc.
- Stock
Last Close
14.04
17/05 20:00
Market Cap
1.87B
Beta: 0.46
Volume Today
5.37M
Avg: 3.65M
PE Ratio
−50.71
PFCF: 68.00
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 3.88M - | 8.55M 120.37% | 17.56M 105.37% | 22.01M 25.36% | ||
average payables | 7.65M - | 13.85M 81.12% | 26.00M 87.70% | 37.72M 45.06% | ||
average receivables | 1.00M - | 2.36M 135.49% | 3.40M 44.12% | 1.62M 52.54% | ||
book value per share | -3.89 - | -4.15 6.73% | 1.79 143.12% | 1.52 14.92% | 0.00 99.89% | |
capex per share | -0.05 - | -0.12 132.89% | -0.03 77.61% | -0.04 32.19% | -0.00 99.77% | |
capex to depreciation | -6.87 - | -4.00 41.73% | -1.23 69.32% | -0.97 21.09% | -1.81 86.65% | |
capex to operating cash flow | 0.02 - | 1.71 7,053.81% | 0.15 91.48% | 0.27 87.73% | -0.23 185.79% | |
capex to revenue | -0.02 - | -0.03 31.46% | -0.02 35.28% | -0.01 25.32% | -0.02 43.58% | |
cash per share | 1.74 - | 2.83 63.20% | 1.32 53.29% | 0.88 33.66% | 0.00 99.88% | |
days of inventory on hand | 40.56 - | 32.90 18.88% | 73.44 123.22% | 66.59 9.33% | 52.21 21.59% | |
days payables outstanding | 69.54 - | 74.90 7.71% | 106.38 42.04% | 99.94 6.06% | 100.10 0.16% | |
days sales outstanding | 3.80 - | 2.81 25.89% | 4.80 70.63% | 2.24 53.39% | ||
debt to assets | 0.02 - | 0.04 73.14% | 0.01 64.19% | 0.01 11.14% | 0.02 55.65% | |
debt to equity | -0.01 - | -0.03 162.66% | 0.02 155.70% | 0.02 3.91% | 0.03 69.86% | |
dividend yield | 0.00 - | |||||
earnings yield | -0.21 - | -0.04 83.24% | -0.09 150.76% | -0.05 43.07% | -0.00 99.97% | |
enterprise value | 322.98M - | 488.82M 51.35% | 1.16B 136.72% | 1.27B 9.71% | 1.86T 146,659.01% | |
enterprise value over ebitda | -4.47 - | -28.89 546.68% | -10.47 63.76% | -20.74 98.05% | -63.26K 304,963.22% | |
ev to operating cash flow | -4.31 - | -197.18 4,470.76% | -33.63 82.95% | -47.85 42.30% | 25.35K 53,087.27% | |
ev to sales | 3.91 - | 3.29 16.00% | 4.26 29.52% | 2.41 43.39% | 2.14K 88,580.82% | |
free cash flow per share | -2.21 - | -0.19 91.39% | -0.21 11.16% | -0.17 21.74% | 0.00 100.16% | |
free cash flow yield | -0.22 - | -0.01 94.16% | -0.03 147.78% | -0.03 20.03% | 0.00 100.12% | |
graham net net | -4.15 - | -4.60 10.92% | 0.91 119.86% | 0.68 26.07% | 0.00 99.90% | |
graham number | 13.47 - | 6.92 48.64% | 4.82 30.35% | 3.32 31.15% | 0.00 99.94% | |
income quality | 1.04 - | 0.14 86.83% | 0.32 133.56% | 0.40 26.38% | -3.12 872.57% | |
intangibles to total assets | 0 - | 0.00 Infinity% | 0.33 65,322.63% | 0.36 11.41% | 0.29 19.01% | |
interest coverage | -201.66 - | -1.51K 650.95% | 22.99 - | |||
interest debt per share | 0.05 - | 0.12 125.96% | 0.03 76.04% | 0.01 61.37% | 0.00 99.58% | |
inventory turnover | 9 - | 11.09 23.27% | 4.97 55.20% | 5.48 10.29% | 6.99 27.54% | |
invested capital | -0.01 - | -0.03 162.66% | 0.02 155.70% | 0.02 3.91% | 0.03 69.86% | |
market cap | 344.11M - | 516.17M 50.00% | 1.22B 137.02% | 1.31B 7.15% | 1.86T 142,023.67% | |
net current asset value | -137.76M - | -152.49M 10.69% | 183.94M 220.63% | 162.00M 11.93% | 167.90M 3.64% | |
net debt to ebitda | 0.29 - | 1.62 452.89% | 0.60 62.88% | 0.68 12.90% | 2.94 334.71% | |
net income per share | -2.07 - | -0.51 75.29% | -0.58 12.50% | -0.32 44.28% | -0.00 99.96% | |
operating cash flow per share | -2.15 - | -0.07 96.74% | -0.18 162.75% | -0.13 29.59% | 0.00 100.27% | |
payables turnover | 5.25 - | 4.87 7.15% | 3.43 29.59% | 3.65 6.45% | 3.65 0.16% | |
receivables turnover | 96.11 - | 129.69 34.94% | 76.01 41.39% | 163.08 114.56% | ||
research and ddevelopement to revenue | 0.08 - | 0.06 - | 0.06 0.33% | |||
return on tangible assets | -1.00 - | -0.15 84.73% | -0.38 148.44% | -0.28 25.89% | -0.08 73.13% | |
revenue per share | 2.38 - | 4.21 77.15% | 1.46 65.41% | 2.58 77.00% | 0.00 99.84% | |
roe | 0.53 - | 0.12 76.85% | -0.32 360.87% | -0.21 34.52% | -0.07 67.51% | |
roic | 0.56 - | 0.11 80.79% | -0.32 402.36% | -0.21 34.15% | -0.07 65.48% | |
sales general and administrative to revenue | 0.68 - | 0.44 34.82% | 0.68 53.15% | 0.19 72.41% | 0.15 20.07% | |
shareholders equity per share | -3.89 - | -4.15 6.73% | 1.79 143.12% | 1.52 14.92% | 0.00 99.89% | |
stock based compensation to revenue | 0.10 - | 0.04 59.69% | 0.25 530.67% | 0.08 67.13% | 0.08 6.74% | |
tangible asset value | -135.29M - | -146.93M 8.60% | 197.85M 234.65% | 179.02M 9.52% | 214.57M 19.86% | |
tangible book value per share | -3.89 - | -4.16 6.78% | 1.06 125.49% | 0.88 17.36% | 0.00 99.88% | |
working capital | 48.98M - | 97.86M 99.77% | 190.68M 94.86% | 168.65M 11.55% | 176.59M 4.70% |
All numbers in USD (except ratios and percentages)